Pacific Biosciences Of California (PACB) Current Assets (2010 - 2026)
Pacific Biosciences Of California's quarterly Current Assets came in at $369.5 million in Q1 2026, down 16.95% year-on-year from $444.9 million in Q1 2025, and down 1.48% quarter-over-quarter from $375.1 million in Q4 2025.
Pacific Biosciences Of California has reported Current Assets for 17 years, with the latest figure at $369.5 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 16.95% year-over-year to $369.5 million; the trailing twelve-month figure through Mar 2026 stood at $369.5 million (down 16.95% YoY), and the FY2025 full-year result was $375.1 million, down 24.34% from the prior year.
- Current Assets for Q1 2026 stood at $369.5 million, down from $375.1 million in the prior quarter.
- The five-year high for Current Assets was $1.0 billion in Q1 2022, with the low at $369.5 million in Q1 2026.
- Average Current Assets over 5 years is $687.6 million, with a median of $677.0 million recorded in 2024.
- Year-over-year, Current Assets slipped 3.46% in 2023 and slumped 34.28% in 2025.
- Tracing PACB's Current Assets over 5 years: stood at $852.1 million in 2022, then retreated by 12.91% to $742.0 million in 2023, then slumped by 33.2% to $495.7 million in 2024, then dropped by 24.34% to $375.1 million in 2025, then fell by 1.48% to $369.5 million in 2026.
- The last three Current Assets figures came in at $369.5 million (Q1 2026), $375.1 million (Q4 2025), and $394.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 24.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.45 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 4.33 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.39 Bn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 369.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369.52 Mn |
| Dec 31, 2025 | 375.05 Mn |
| Sep 30, 2025 | 394.24 Mn |
| Jun 30, 2025 | 413.40 Mn |
| Mar 31, 2025 | 444.92 Mn |
| Dec 31, 2024 | 495.68 Mn |
| Sep 30, 2024 | 584.23 Mn |
| Jun 30, 2024 | 628.14 Mn |
| Mar 31, 2024 | 677.02 Mn |
| Dec 31, 2023 | 742.05 Mn |
| Sep 30, 2023 | 882.30 Mn |
| Jun 30, 2023 | 935.55 Mn |
| Mar 31, 2023 | 981.11 Mn |
| Dec 31, 2022 | 852.07 Mn |
| Sep 30, 2022 | 913.90 Mn |
| Jun 30, 2022 | 970.29 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Jun 30, 2021 | 1.19 Bn |
| Mar 31, 2021 | 1.20 Bn |
| Dec 31, 2020 | 355.59 Mn |
| Sep 30, 2020 | 239.51 Mn |
| Jun 30, 2020 | 150.94 Mn |
| Mar 31, 2020 | 169.53 Mn |
| Dec 31, 2019 | 81.05 Mn |
| Sep 30, 2019 | 76.94 Mn |
| Jun 30, 2019 | 98.91 Mn |
| Mar 31, 2019 | 112.59 Mn |
| Dec 31, 2018 | 131.66 Mn |
| Sep 30, 2018 | 143.87 Mn |
| Jun 30, 2018 | 96.41 Mn |
| Mar 31, 2018 | 115.70 Mn |
| Dec 31, 2017 | 101.62 Mn |
| Sep 30, 2017 | 113.61 Mn |
| Jun 30, 2017 | 132.93 Mn |
| Mar 31, 2017 | 88.34 Mn |
| Dec 31, 2016 | 109.01 Mn |
| Sep 30, 2016 | 122.47 Mn |
| Jun 30, 2016 | 138.06 Mn |
| Mar 31, 2016 | 119.05 Mn |
| Dec 31, 2015 | 110.54 Mn |
| Sep 30, 2015 | 86.21 Mn |
| Jun 30, 2015 | 90.19 Mn |
| Mar 31, 2015 | 99.52 Mn |
| Dec 31, 2014 | 117.76 Mn |
| Sep 30, 2014 | 114.14 Mn |
| Jun 30, 2014 | 119.90 Mn |
| Mar 31, 2014 | 132.06 Mn |
| Dec 31, 2013 | 126.46 Mn |
| Sep 30, 2013 | 141.76 Mn |
| Jun 30, 2013 | 122.11 Mn |
| Dec 31, 2012 | 115.00 Mn |
| Mar 31, 2012 | 176.81 Mn |
| Dec 31, 2011 | 199.60 Mn |
| Sep 30, 2011 | 220.28 Mn |
| Jun 30, 2011 | 244.73 Mn |
| Dec 31, 2010 | 293.11 Mn |